BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22711249)

  • 1. [Radiological diagnosis and intervention of cholangiocarcinomas (CC)].
    Vogl TJ; Zangos S; Eichler K; Gruber-Rouh T; Hammerstingl RM; Trojan J; Weisser P
    Rofo; 2012 Oct; 184(10):883-92. PubMed ID: 22711249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma: risk factors, diagnosis and management.
    Acalovschi M
    Rom J Intern Med; 2004; 42(1):41-58. PubMed ID: 15529594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholangiocarcinoma--bile ducts cancer].
    Dubaniewicz A; Dubaniewicz A
    Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and surgical treatment of hepatic hilar cholangiocarcinoma.
    Yang WL; Zhang XC; Zhang DW; Tong BF
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):631-5. PubMed ID: 18086631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholangiocarcinoma.
    Coelho-Prabhu N; Baron TH
    Clin Liver Dis; 2010 May; 14(2):333-48. PubMed ID: 20682239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modern approach to malignant hilar biliary obstruction.
    Freeman ML; Sielaff TD
    Rev Gastroenterol Disord; 2003; 3(4):187-201. PubMed ID: 14668691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional computed tomographic cholangiography as a novel diagnostic tool for evaluation of bile duct invasion of perihilar cholangiocarcinoma.
    Ajiki T; Fukumoto T; Ueno K; Okazaki T; Matsumoto I; Ku Y
    Hepatogastroenterology; 2013; 60(128):1833-8. PubMed ID: 24719915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MRCP (magnetic resonance cholangiopancreatography)--an assessment of current status].
    Merkle EM; Nüssle K; Glasbrenner B; Tomczak R; Preclik G; Rieber A; Adler G; Brambs HJ
    Z Gastroenterol; 1998 Mar; 36(3):215-24. PubMed ID: 9577905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.
    Yeh TS; Jan YY; Tseng JH; Chiu CT; Chen TC; Hwang TL; Chen MF
    Am J Gastroenterol; 2000 Feb; 95(2):432-40. PubMed ID: 10685746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative assessment of cholangiocarcinoma: meeting the challenge.
    Garg PK; Tandon RK
    J Gastroenterol Hepatol; 1999 Jul; 14(7):615-7. PubMed ID: 10440205
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant biliary obstruction: value of imaging findings.
    Stroszczynski C; Hunerbein M
    Abdom Imaging; 2005; 30(3):314-23. PubMed ID: 15965779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma: an endoscopist's perspective.
    Atiq M; Javle M; Dang S; Lee JH
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):601-11. PubMed ID: 20932145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcionoma and primary sclerosing cholangitis: the answer lies within.
    Shah RJ
    Gastrointest Endosc; 2014 May; 79(5):780-2. PubMed ID: 24721627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Obscure bile duct stenosis: diagnostic management].
    Riemann JF; Damian U; Weickert U
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S133-4. PubMed ID: 15368193
    [No Abstract]   [Full Text] [Related]  

  • 16. MRCP and 3D LAVA imaging of extrahepatic cholangiocarcinoma at 3 T MRI.
    Li N; Liu C; Bi W; Lin X; Jiao H; Zhao P
    Clin Radiol; 2012 Jun; 67(6):579-86. PubMed ID: 22137873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of MR cholangiopancreatography combining with dynamic enhanced MRI in the detection of cholangiocarcinoma].
    Tian J; Lu JP; Wang J; Wang F; Liu Q; Wang L; Gong JG; Jin AG; Zeng H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):526-9. PubMed ID: 14552710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma: a review.
    Thuluvath PJ; Rai R; Venbrux AC; Yeo CJ
    Gastroenterologist; 1997 Dec; 5(4):306-15. PubMed ID: 9436006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal cholangiocarcinoma: a multidisciplinary approach.
    van der Hul RL; Plaisier PW; Laméris JS; Veeze-Kuijpers B; van Blankenstein M; Terpstra OT
    Eur J Surg; 1994 Apr; 160(4):213-8. PubMed ID: 8049311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.